Surrozen, Inc. Common SRZN

$29.50 -3.81% at last close
Market Cap$584.62 million
P/E Ratio—
Div Yield—
Volume18.0K
52-Week Range $11.39$37.83

Analyst Ratings

Consensus
Buy — 5 Buy · 0 Hold · 0 Sell (5 analysts)
Avg. Price Target
$65.33 (+121.5% upside)

Full SRZN forecast & analyst actions →

Key Stats

Today's Range
$29.36 – $30.34
50-Day Range
$16.14 – $37.83
52-Week Range
$11.39 – $37.83
Volume
18K shs
Average Volume
339K shs
Market Cap
$584.62 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.20%
Days to Cover
1.00

About Surrozen, Inc. Common

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
44
Exchange
XNAS
Listed
2021-08-12

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.